Seeking Alpha

Vertex Pharmaceuticals (VRTX): Q4 EPS of $0.04 beats by $0.11. Revenue of $334M beats by $16M....

Vertex Pharmaceuticals (VRTX): Q4 EPS of $0.04 beats by $0.11. Revenue of $334M beats by $16M. Sees FY13 revenue of $1.10B - 1.25B, versus consensus of $1.16B. (PR).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|